Learning Objectives
By the end of this program, participants will be able to:
- Outline benefits of initiating antiretroviral therapy (ART) regimens for new HIV diagnoses (including rapid ART), counteracting suboptimal dosing, and maintaining engagement in care.
- Demonstrate approaches and tools the clinical care team can use to support treatment adherence, including with clients who have recently received an HIV diagnosis or are struggling to adhere to ART.
- Describe motivational interviewing and its collaborative, goal-oriented style of communication with particular attention to the language of change.
- List, describe, and demonstrate the “do’s” and “don’ts” of motivational interviewing that elicit and strengthen motivation for change in people with HIV.
Speaker
Sarah Lim, MD
Assistant Professor, University of Pittsburgh School of Medicine
Physician, University of Pittsburgh Medical Center
Associate Director, The Center for Public Service Psychiatry
Accreditation
You are only eligible for continuing education or a certificate of attendance if you register, attend the full program, and then complete all required evaluations within 1 week of the program.
Nursing: The MidAtlantic AIDS Education and Training Center is approved as a provider of nursing continuing professional development by the Pennsylvania State Nurses Association Approver Unit an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This event is eligible for 1.0 credit hours.
Certificate of Attendance
Certificates of Attendance and continuing education certificates will be sent out via email 4-6 weeks after the event has completed.
Continuing Education credits issued for participation in CE activity may not apply toward license renewal in all states. It is the responsibility of each participant to verify the requirements of their state licensing board(s).
ACKNOWLEDGEMENT:
The MidAtlantic AIDS Education and Training Center (MAAETC) is supported by DHHS, Health Resources and Services Administration (HRSA) as part of a cooperative agreement of $2,917,621 and 0% financed with non-governmental sources. Additional funding provided by the Pennsylvania Department of Health (PA DOH), Bureau of Communicable Diseases, Division of HIV Disease. The views expressed do not necessarily reflect the official policies of the Department of Health and Human Services nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Any trade names for products mentioned are for training and identification purposes only. The contents of this material are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. Funding was made possible in part by TR7HA53201-01-00 from the HRSA, HIV/AIDS Bureau. For more information, please visit HRSA.gov.
